The expression of myeloid antigens CD13 and CD33 in B-lymphoblastic leukemia/lymphoma is typically observed in B-lymphoblastic leukemia/lymphoma with BCR::ABL1 fusion [2]. This evidence concerns the gene ABL1 and lymphoma.